These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19204133)

  • 1. A pilot study testing a medication algorithm to reduce polypharmacy.
    Mistler LA; Mellman TA; Drake RE
    Qual Saf Health Care; 2009 Feb; 18(1):55-8. PubMed ID: 19204133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy with second-generation antipsychotics: a review of evidence.
    Pandurangi AK; Dalkilic A
    J Psychiatr Pract; 2008 Nov; 14(6):345-67. PubMed ID: 19057237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.
    Thompson A; Sullivan SA; Barley M; Strange SO; Moore L; Rogers P; Sipos A; Harrison G
    Psychol Med; 2008 May; 38(5):705-15. PubMed ID: 17825122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
    Peindl KS; Masand P; Mannelli P; Narasimhan M; Patkar A
    J Psychiatr Pract; 2007 Nov; 13(6):385-92. PubMed ID: 18032983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients.
    Procyshyn RM; Honer WG; Wu TK; Ko RW; McIsaac SA; Young AH; Johnson JL; Barr AM
    J Clin Psychiatry; 2010 May; 71(5):566-73. PubMed ID: 20361903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy.
    Chong SA; Ravichandran N; Poon LY; Soo KL; Verma S
    Ann Acad Med Singap; 2006 Jul; 35(7):457-60. PubMed ID: 16902720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic dosage regimens in psychotic inpatients: a retrospective comparison.
    Vuckovic A; Cohen BM; Keck PE; Shedlack KJ
    J Clin Psychiatry; 1990 Mar; 51(3):107-9. PubMed ID: 1968456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When less is more: reducing the incidence of antipsychotic polypharmacy.
    Tucker WM
    J Psychiatr Pract; 2007 May; 13(3):202-4. PubMed ID: 17522566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
    Novak L; Svab V
    Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.
    Bauer M; Pfennig A; Linden M; Smolka MN; Neu P; Adli M
    J Clin Psychopharmacol; 2009 Aug; 29(4):327-33. PubMed ID: 19593170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
    Case BG; Patrick L; Peselow ED
    Am J Psychiatry; 2005 Mar; 162(3):632; author reply 632-3. PubMed ID: 15741498
    [No Abstract]   [Full Text] [Related]  

  • 15. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic polypharmacy at admission predicts extended length of stay among state hospital inpatients.
    Lacasse JR
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1065. PubMed ID: 24835210
    [No Abstract]   [Full Text] [Related]  

  • 17. Audit of antipsychotic polypharmacy in Christchurch.
    McKean A; Vella-Brincat J
    Australas Psychiatry; 2009 Aug; 17(4):336-7. PubMed ID: 19585299
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records.
    Buck MD; Atreja A; Brunker CP; Jain A; Suh TT; Palmer RM; Dorr DA; Harris CM; Wilcox AB
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):84-92. PubMed ID: 19447361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How everyone recognize about polypharmacy?].
    Yamanouchi Y
    Seishin Shinkeigaku Zasshi; 2012; 114(6):683-9. PubMed ID: 22844819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.